- In April 2023, Medtronic plc, a global leader in medical technology, launched the Micra AV2 and VR2, next-generation leadless pacemakers designed to offer longer battery life and improved programming capabilities. These advanced devices enable more personalized therapy for patients with bradycardia and atrioventricular block, reinforcing Medtronic's leadership in minimally invasive cardiac implantables and expanding patient access to leadless pacing solutions worldwide
- In March 2023, Abbott Laboratories received expanded FDA approval for its Proclaim XR spinal cord stimulation system, now indicated for use in diabetic peripheral neuropathy. This development underscores Abbott’s commitment to addressing the growing burden of chronic pain through advanced neurostimulation solutions, enhancing the therapeutic reach of implantable devices in managing complex neurological conditions
- In March 2023, Boston Scientific Corporation unveiled its Vercise Neural Navigator 5 platform in Europe, enhancing precision and ease of programming for deep brain stimulation therapies. The system supports patients with Parkinson’s disease and dystonia by delivering more targeted and adaptable stimulation, highlighting the company's innovation in neurotechnology and its focus on improving patient outcomes in movement disorders
- In February 2023, Cochlear Limited announced the launch of the Cochlear Nucleus SmartNav System, a digital surgical guidance tool that provides real-time feedback during cochlear implant surgery. This solution is designed to improve placement accuracy and surgical outcomes, marking a significant advancement in implantable hearing devices and surgical navigation for audiology professionals
- In January 2023, Biotronik SE & Co. KG introduced the BIOMONITOR IV, an insertable cardiac monitor with enhanced detection algorithms and remote monitoring capabilities. The device enables continuous, long-term heart rhythm assessment and is part of Biotronik’s expanding portfolio of intelligent, patient-centric cardiac care solutions. This innovation supports proactive care management and reinforces the role of smart implantable technologies in cardiology
